BSE filing, NSE: TEJNAKSH. Summary written from the filing by ALFA Finder's alert engine.
Tejnaksh Healthcare Ltd: key numbers
- Share price
- ₹12.89
- Market cap
- ₹26.18 Cr
- Revenue (annual)
- ₹10.79 Cr
- Net profit (annual)
- ₹1.23 Cr
- P/E (TTM)
- 21.2×Sector 51.1×
- Promoter holding
- 73.83%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Tejnaksh Healthcare Ltd
All →Tejnaksh Healthcare Business Update
Tejnaksh Healthcare announced publication of a multicentric validation study of its Pflow device in the Indian Journal of Urology. The filing is a scientific publication update with no financial value.
Tejnaksh Healthcare Other Announcement
Tejnaksh Healthcare Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with Regulation 31(1)(b) of SEBI LODR.
Tejnaksh Healthcare Annual General Meeting
The company issued a notice for its Annual General Meeting scheduled for September 29, 2026, to consider financial statements, director appointments, and related party transaction approvals.
Tejnaksh Healthcare Annual Report
Tejnaksh Healthcare Limited has submitted its Annual Report for the financial year 2025-26. The filing includes audited standalone and consolidated financial statements along with governance reports.
Tejnaksh Healthcare Annual General Meeting
Tejnaksh Healthcare Ltd will hold its 19th Annual General Meeting on September 29, 2026. The meeting will be conducted via video conferencing to transact ordinary and special business.
Tejnaksh Healthcare Q1 FY27 Results: Net Profit ₹0.3 Cr, Up 50.0% YoY
Tejnaksh Healthcare Ltd reported revenue from operations of ₹2.7 Cr (+3.8% YoY) and net profit of ₹0.3 Cr (+50.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.3 Cr · +50.0% YoY
Other management change announcements
All →Sayaji Hotels (Indore) Management Change
Sayaji Hotels (Indore) appointed Azhar Yusuf Dhanani as Additional Non-Executive Non-Independent Director effective October 28, 2026. Shareholder approval is required within three months.
Fabtech Technologies Management Change
FABTECH Technologies appointed Mr. Alan Dias as Vice President - HR, a senior management personnel role, effective October 28, 2026. He brings over 24 years of human resources experience.
Parmax Pharma Management Change
Parmax Pharma's independent director Ami Shah resigned effective October 28, 2026. The exit follows a change in management and control of the company.
Sagarsoft (India) Management Change
Sagarsoft (India) appointed Ms. Arcot Ganeshan Monisha as Company Secretary and Compliance Officer, designated as KMP, effective 28 October 2026. Details are provided per Regulation 30 in the annexure.
Chemfab Alkalis Management Change
Chemfab Alkalis approved unaudited Q2/H1 results, committee re-designations, and appointed V. R. Raguraman as Chief Operating Officer (SMP). The senior management appointment is the filing's main business event.
Aeroflex Industries Management Change
Aeroflex Industries reports Drashti Bhil's change from Deputy CFO to CFO, plus Mustafa Kachwala's tenure completion as CFO effective 27 November 2026. Management reshuffle with no money or business event.